Shares of Vertex, Inc. (NASDAQ:VERX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from ...
Zacks Investment Research on MSN12d
Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?Vertex Pharmaceuticals Incorporated VRTX stock has plunged 25.3% this year so far against the industry’s 5.4% increase. VRTX ...
Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...
The price target increase by Truist Securities indicates confidence in Vertex's drug portfolio and strategic positioning ...
According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
Fairman Group LLC purchased a new position in Vertex in the 4th quarter worth approximately $327,000. Empowered Funds LLC bought a new stake in shares of Vertex during the 4th quarter worth ...
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Vertex (VERX – Research Report) and AppLovin ...
Vertex’s strong execution continued in the ... In conclusion, we continue to benefit from our position at the intersection of commerce and compliance in a way that enables durable and profitable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback